ADSL

UniProt ID: P30566
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

Adenylosuccinate lyase (ADSL; adenylosuccinase; EC 4.3.2.2) is a cytosolic homotetrameric enzyme of purine metabolism that catalyses two distinct beta-elimination (fumarate-releasing) reactions in the same active site. In de novo purine synthesis it cleaves SAICAR ((S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate) to AICAR plus fumarate, completing the step 2/2 that converts SAICAR toward IMP; and at the IMP-to-AMP branch it cleaves adenylosuccinate (S-AMP) to AMP plus fumarate. The enzyme therefore contributes to both de novo IMP biosynthesis and de novo AMP biosynthesis. It assembles as a homotetramer in which three subunits contribute residues to each of the four active sites, and can associate with other de novo purine synthesis enzymes in the purinosome. Loss-of-function variants cause adenylosuccinate lyase deficiency (ADSLD), an autosomal-recessive neurodevelopmental disorder marked by psychomotor/mental retardation, epilepsy and autistic features, with accumulation of the dephosphorylated substrates SAICA-riboside and succinyladenosine in body fluids.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0070626 (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity
IBA
GO_REF:0000033
ACCEPT
Summary: SAICAR-lyase (fumarate-forming) activity, one of the two core catalytic functions of ADSL. This IBA is fully consistent with the human experimental data and the enzyme's role in de novo IMP synthesis.
Reason: This is a core molecular function of ADSL, cleaving SAICAR to AICAR plus fumarate as step 2/2 of the de novo IMP pathway. The phylogenetic inference matches the human IDA (PMID:27590927) and UniProt.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
Catalyzes two non-sequential steps in de novo AMP synthesis
PMID:19405474
the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and fumarate
GO:0004018 N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
IBA
GO_REF:0000033
ACCEPT
Summary: Adenylosuccinate (S-AMP) lyase (fumarate-forming) activity, the second core catalytic function of ADSL, cleaving S-AMP to AMP plus fumarate at the IMP-to-AMP branch.
Reason: Core molecular function, corroborated by human IDA data (PMID:19405474, PMID:16973378) and UniProt catalytic-activity annotation (EC 4.3.2.2, Rhea RHEA:16853).
Supporting Evidence:
PMID:19405474
the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
GO:0005829 cytosol
IBA
GO_REF:0000033
ACCEPT
Summary: ADSL is a cytosolic enzyme; its active form is a cytosolic tetramer. This localization is supported by IBA, IDA (HPA) and TAS (Reactome).
Reason: Cytosolic localization is well established and consistent across phylogenetic, immunofluorescence and Reactome evidence.
Supporting Evidence:
Reactome:R-HSA-73800
The active form of this enzyme is a cytosolic tetramer
GO:0044208 'de novo' AMP biosynthetic process
IBA
GO_REF:0000033
ACCEPT
Summary: ADSL catalyses the final step (S-AMP to AMP) of de novo AMP biosynthesis from IMP. This is a core biological process for the gene.
Reason: The SAMP-to-AMP reaction is AMP-from-IMP step 2/2 of the de novo AMP pathway, as stated in the UniProt PATHWAY annotation. IBA is at the correct level.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
AMP biosynthesis via de novo pathway; AMP
GO:0003824 catalytic activity
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: Root-level catalytic activity term from InterPro2GO. Not wrong, but far too general given the two specific lyase activities (GO:0004018, GO:0070626) are already annotated with experimental evidence.
Reason: This is an uninformative parent of the specific molecular functions ADSL is already annotated to. It adds no information beyond the specific lyase terms.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
Catalyzes two non-sequential steps in de novo AMP synthesis
GO:0004018 N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic annotation (ARBA/RHEA:16853) of the S-AMP lyase activity, redundant with and corroborated by the experimental IDA annotations.
Reason: Correct molecular function derived from the EC/Rhea mapping; matches the human experimental data.
Supporting Evidence:
PMID:19405474
the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
GO:0009152 purine ribonucleotide biosynthetic process
IEA
GO_REF:0000002
ACCEPT
Summary: General purine ribonucleotide biosynthesis process, correctly capturing ADSL's role in de novo IMP/AMP synthesis, though broader than the specific de novo terms.
Reason: A correct, if general, biological-process parent. ADSL participates in purine ribonucleotide biosynthesis via de novo IMP and AMP synthesis.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
Catalyzes two non-sequential steps in de novo AMP synthesis
GO:0001666 response to hypoxia
IEA
GO_REF:0000107
REMOVE
Summary: Stimulus-response process transferred electronically from a rat ortholog via Ensembl Compara. There is no evidence that human ADSL functions as an effector in the hypoxia response; this is an over-propagated ortholog IEA.
Reason: ADSL is a cytosolic purine-biosynthesis lyase. "Response to hypoxia" is a stimulus-response biological process not supported by any experimental data for ADSL, and is a classic Ensembl-Compara over-propagation from an ortholog.
GO:0006167 AMP biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: AMP biosynthetic process (general parent of de novo AMP biosynthesis), correctly capturing ADSL's production of AMP from S-AMP.
Reason: ADSL produces AMP as the second step of AMP-from-IMP; this general term is correct and is also supported by the human IDA (PMID:11428554).
Supporting Evidence:
PMID:19405474
the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
GO:0006177 GMP biosynthetic process
IEA
GO_REF:0000107
REMOVE
Summary: GMP biosynthesis is not catalysed or supported by ADSL. GMP is produced from IMP by IMP dehydrogenase and GMP synthase; ADSL acts on the AMP branch, not the GMP branch.
Reason: Biochemically incorrect. ADSL has no role in GMP synthesis; this is an erroneous Ensembl-Compara ortholog transfer. The enzyme's reactions (SAICAR to AICAR, and S-AMP to AMP) lie on the IMP and AMP branches only.
GO:0006189 'de novo' IMP biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: ADSL contributes to de novo IMP biosynthesis via its SAICAR-lyase step (SAICAR to AICAR + fumarate), which is step 2/2 in the conversion of SAICAR toward IMP. Core biological process.
Reason: Correct core process. The UniProt PATHWAY annotation places this SAICAR-lyase reaction within de novo IMP biosynthesis.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
IMP biosynthesis via de novo pathway
GO:0007584 response to nutrient
IEA
GO_REF:0000107
REMOVE
Summary: Stimulus-response process transferred electronically from a rat ortholog. No experimental support for human ADSL acting as a nutrient-response effector.
Reason: Over-propagated Ensembl-Compara ortholog IEA; not a supportable molecular role for human ADSL, which is a constitutive purine-biosynthesis enzyme.
GO:0009060 aerobic respiration
IEA
GO_REF:0000107
REMOVE
Summary: Aerobic respiration is a mitochondrial process; ADSL is a cytosolic purine-biosynthesis lyase. Fumarate release by ADSL does not constitute participation in aerobic respiration.
Reason: Biologically incorrect over-propagation via Ensembl Compara. ADSL is not part of the respiratory chain or TCA cycle; its product fumarate feeds general metabolism but that does not make ADSL a participant in aerobic respiration.
GO:0014850 response to muscle activity
IEA
GO_REF:0000107
REMOVE
Summary: Although ADSL is highly expressed in skeletal muscle and participates in the purine nucleotide cycle there, "response to muscle activity" is a stimulus-response biological process electronically transferred from a rat ortholog, without experimental support for human ADSL as an effector of this response.
Reason: Over-propagated Ensembl-Compara ortholog IEA. Muscle expression does not justify a stimulus-response BP annotation; ADSL's role in muscle is its constitutive purine-cycle catalysis.
GO:0042594 response to starvation
IEA
GO_REF:0000107
REMOVE
Summary: Stimulus-response process transferred electronically from a rat ortholog. No experimental support for human ADSL as a starvation-response effector.
Reason: Over-propagated Ensembl-Compara ortholog IEA, not supportable for human ADSL.
GO:0042802 identical protein binding
IEA
GO_REF:0000107
KEEP AS NON CORE
Summary: Self-association is real (ADSL is a homotetramer), but "identical protein binding" is an uninformative molecular-function term compared with the enzyme's catalytic activities and its "protein-containing complex" annotation. This IEA duplicates the IDA below.
Reason: The homotetrameric assembly makes identical-protein binding technically correct, but it is non-core relative to the catalytic MFs. Retain as non-core; the homotetramer is better captured by GO:0032991 and the SUBUNIT annotation.
Supporting Evidence:
PMID:19405474
ASL, a catalyst of key reactions in purine biosynthesis, is normally a homotetramer in which three subunits contribute to each of four active sites
GO:0044208 'de novo' AMP biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic annotation of de novo AMP biosynthesis (UniPathway UPA00075), redundant with the IBA and consistent with the S-AMP-to-AMP reaction.
Reason: Correct core process, matching the UniProt de novo AMP biosynthesis pathway annotation.
Supporting Evidence:
file:human/ADSL/ADSL-uniprot.txt
AMP biosynthesis via de novo pathway; AMP
GO:0044209 AMP salvage
IEA
GO_REF:0000107
MARK AS OVER ANNOTATED
Summary: ADSL produces AMP as part of DE NOVO purine synthesis (and the purine nucleotide cycle), not the salvage pathway. AMP salvage refers to recovery of AMP from adenine/adenosine via APRT and adenosine kinase, in which ADSL plays no part.
Reason: Misleading Ensembl-Compara ortholog IEA. ADSL's S-AMP-to-AMP reaction is de novo AMP biosynthesis, correctly captured by GO:0044208/GO:0006167; annotating it to AMP salvage misassigns the pathway context.
GO:0070626 (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic annotation (ARBA/RHEA:23920) of the SAICAR-lyase activity, redundant with and corroborated by the human IDA and IBA annotations.
Reason: Correct core molecular function from the EC/Rhea mapping; matches the human experimental data (PMID:27590927).
Supporting Evidence:
PMID:19405474
the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and fumarate
GO:0097294 'de novo' XMP biosynthetic process
IEA
GO_REF:0000107
REMOVE
Summary: XMP is synthesized from IMP by IMP dehydrogenase; ADSL is not involved in the XMP branch. This is an erroneous Ensembl-Compara ortholog transfer.
Reason: Biochemically incorrect. ADSL acts on the SAICAR-to-IMP and IMP-to-AMP branches, not on the IMP-to-XMP branch. No support for XMP biosynthesis.
GO:0005829 cytosol
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence (HPA) localizes ADSL to the cytosol, consistent with the enzyme's cytosolic tetrameric active form.
Reason: Direct experimental (HPA immunofluorescence) evidence for cytosolic localization, concordant with IBA and Reactome TAS.
Supporting Evidence:
Reactome:R-HSA-73800
The active form of this enzyme is a cytosolic tetramer
GO:0004018 N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
IDA
PMID:19405474
Biochemical and biophysical analysis of five disease-associa...
ACCEPT
Summary: Direct assay of the S-AMP-to-AMP + fumarate reaction on purified recombinant human ADSL and disease-associated mutants. Core molecular function.
Reason: Strong direct experimental evidence for the adenylosuccinate (S-AMP) lyase activity, measured continuously as SAMP is converted to AMP and fumarate.
Supporting Evidence:
PMID:19405474
as 60 ΞΌM SAMP is converted to AMP and fumarate
GO:0070626 (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate lyase (fumarate-forming) activity
IDA
PMID:27590927
CRISPR-Cas9 induced mutations along de novo purine synthesis...
ACCEPT
Summary: SAICAR-lyase activity demonstrated in the context of de novo purine synthesis; CRISPR knockout of ADSL in HeLa cells leads to accumulation of its substrate, confirming the in vivo lyase step. Core molecular function.
Reason: Direct experimental evidence supporting the SAICAR-lyase activity; substrate accumulation on knockout confirms the enzyme performs this step in cells.
Supporting Evidence:
PMID:27590927
an accumulation of the substrate(s) for the knocked out enzyme was identified
GO:0032991 protein-containing complex
IDA
PMID:16973378
Expression, purification, and characterization of stable, re...
KEEP AS NON CORE
Summary: ADSL is a homotetramer, i.e. a protein-containing complex. Direct evidence from analytical ultracentrifugation of the purified recombinant enzyme (tetramer, ~220 kDa). Correct but very general.
Reason: The homotetrameric assembly is real and experimentally demonstrated, but "protein-containing complex" is an uninformative CC parent; the specific homotetramer state is better described in the SUBUNIT annotation. Retain as non-core.
Supporting Evidence:
PMID:16973378
the histidine-tagged enzyme is in tetrameric form with a molecular weight of 220 kDa
file:human/ADSL/ADSL-uniprot.txt
Homotetramer. Residues from neighboring subunits contribute catalytic and substrate-binding residues to each active site.
GO:0042802 identical protein binding
IDA
PMID:16973378
Expression, purification, and characterization of stable, re...
KEEP AS NON CORE
Summary: Self-association into a homotetramer is experimentally demonstrated (analytical ultracentrifugation). "Identical protein binding" is technically correct but uninformative relative to the catalytic MFs and the complex annotation.
Reason: Homo-oligomerization is real (homotetramer), so the term is not wrong, but per curation guidelines bare binding terms are non-core; the functionally informative annotations are the two lyase MFs and GO:0032991. Retain as non-core.
Supporting Evidence:
PMID:16973378
the histidine-tagged enzyme is in tetrameric form with a molecular weight of 220 kDa
GO:0005829 cytosol
TAS
Reactome:R-HSA-73800
ACCEPT
Summary: Reactome (SAICAR => AICAR + Fumarate) places ADSL in the cytosol; the active enzyme is a cytosolic tetramer. Concordant with IDA and IBA.
Reason: Traceable author statement supporting cytosolic localization, consistent with all other localization evidence.
Supporting Evidence:
Reactome:R-HSA-73800
The active form of this enzyme is a cytosolic tetramer
GO:0005829 cytosol
TAS
Reactome:R-HSA-73828
ACCEPT
Summary: Reactome (adenylosuccinate => AMP + fumarate) places ADSL in the cytosol; the active enzyme is a cytosolic tetramer.
Reason: Traceable author statement supporting cytosolic localization, consistent with all other localization evidence.
Supporting Evidence:
Reactome:R-HSA-73828
The active form of this enzyme is a cytosolic tetramer
GO:0006164 purine nucleotide biosynthetic process
IC
PMID:10888601
Human adenylosuccinate lyase (ADSL), cloning and characteriz...
ACCEPT
Summary: Curator inference (from the SAMP-lyase activity, GO:0004018) that ADSL is involved in purine nucleotide biosynthesis. Correct general biological process.
Reason: ADSL is a bifunctional enzyme of de novo purine synthesis and purine nucleotide recycling; the general purine nucleotide biosynthetic process term is appropriate.
Supporting Evidence:
PMID:10888601
Adenylosuccinate lyase (ADSL) is a bifunctional enzyme acting in de novo purine synthesis and purine nucleotide recycling
GO:0006167 AMP biosynthetic process
IDA
PMID:11428554
Determination, activity and biological role of adenylosuccin...
ACCEPT
Summary: ADSL activity measured in blood cells, with the study discussing its role in regulating cellular AMP levels. Supports involvement in AMP biosynthesis.
Reason: Direct measurement of ADSL activity and its role in cellular AMP regulation; consistent with the enzyme's S-AMP-to-AMP reaction in de novo AMP synthesis.
Supporting Evidence:
PMID:11428554
The biological role of adenylosuccinate lyase and its importance in regulating cellular levels of AMP is discussed
GO:0004018 N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
IDA
PMID:16973378
Expression, purification, and characterization of stable, re...
ACCEPT
Summary: Recombinant human ADSL was characterized for its S-AMP lyase activity, with kinetic parameters (Vmax, Km) determined for S-AMP. Core molecular function.
Reason: Direct experimental characterization of the adenylosuccinate (S-AMP) lyase activity of purified human ADSL, defining EC 4.3.2.2 for the human enzyme.
Supporting Evidence:
PMID:16973378
The histidine-tagged and non-tagged adenylosuccinate lyases exhibit similar values of Vmax and Km for S-AMP

Core Functions

Adenylosuccinate (S-AMP) lyase activity - cleaves N6-(1,2-dicarboxyethyl)-AMP (S-AMP) to AMP and fumarate, the second step of de novo AMP biosynthesis from IMP.

Supporting Evidence:
  • PMID:19405474
    the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
  • PMID:16973378
    The histidine-tagged and non-tagged adenylosuccinate lyases exhibit similar values of Vmax and Km for S-AMP

SAICAR-lyase activity - cleaves SAICAR to AICAR and fumarate, step 2/2 of de novo IMP biosynthesis, contributing to purine nucleotide biosynthesis.

Supporting Evidence:
  • PMID:19405474
    the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) and fumarate
  • PMID:27590927
    an accumulation of the substrate(s) for the knocked out enzyme was identified

References

Gene Ontology annotation through association of InterPro records with GO terms
Annotation inferences using phylogenetic trees
Gene Ontology annotation based on curation of immunofluorescence data
Automatic transfer of experimentally verified manual GO annotation data to orthologs using Ensembl Compara
Combined Automated Annotation using Multiple IEA Methods
Human adenylosuccinate lyase (ADSL), cloning and characterization of full-length cDNA and its isoform, gene structure and molecular basis for ADSL deficiency in six patients.
Determination, activity and biological role of adenylosuccinate lyase in blood cells.
Expression, purification, and characterization of stable, recombinant human adenylosuccinate lyase.
Biochemical and biophysical analysis of five disease-associated human adenylosuccinate lyase mutants.
CRISPR-Cas9 induced mutations along de novo purine synthesis in HeLa cells result in accumulation of individual enzyme substrates and affect purinosome formation.
Reactome:R-HSA-73800
SAICAR => AICAR + Fumarate
Reactome:R-HSA-73828
adenylosuccinate => adenosine 5'-monophosphate + fumarate
file:human/ADSL/ADSL-uniprot.txt
UniProtKB P30566 (PUR8_HUMAN) adenylosuccinate lyase record

πŸ“š Additional Documentation

Notes

(ADSL-notes.md)

ADSL (adenylosuccinate lyase) β€” review notes

UniProtKB:P30566 (PUR8_HUMAN). HGNC:291. EC 4.3.2.2. Chromosome 22q13.1.
Lyase 1 family, adenylosuccinate lyase subfamily.

Deep research status: falcon provider out of credits (HTTP 402); no
-deep-research-falcon.md generated. Review grounded in the cached UniProt
record, the seeded GOA, cached publications (PMID_10888601, 11428554, 16973378,
19405474, 27590927), and the two cached Reactome entries. PMID:19405474 is the
only one with full text available in the cache; the others are abstract-only.

Core biology

ADSL is a homotetrameric cytosolic enzyme that catalyses two distinct
beta-elimination (fumarate-releasing) reactions
in purine metabolism, both in
the same active site (three subunits contribute residues to each of the four
active sites):

  1. SAICAR lyase (de novo IMP branch): (S)-2-(5-amino-1-(5-phospho-D-ribosyl)
    imidazole-4-carboxamido)succinate (SAICAR) β†’ AICAR + fumarate.
    Rhea:RHEA:23920 β†’ GO:0070626.
  2. Adenylosuccinate (S-AMP) lyase (IMP→AMP branch): N6-(1,2-dicarboxyethyl)-
    AMP (SAMP) β†’ AMP + fumarate. Rhea:RHEA:16853 β†’ GO:0004018.

Both activities reside at the same active site; a single competitive inhibitor
(APBADP) blocks both, showing the two substrates occupy the same site
[PMID:19405474 full text].

Key verbatim support:
- UniProt FUNCTION: "Catalyzes two non-sequential steps in de novo AMP synthesis"
and "converts succinyladenosine monophosphate (SAMP) to AMP and fumarate."
- PMID:19405474: "Adenylosuccinate lyase (EC 4.3.2.2) catalyzes two Ξ²-elimination
reactions in the de novo synthesis of purines: the cleavage of adenylosuccinate
(SAMP)1 to AMP and fumarate; and the conversion of 5-aminoimidazole-4-
(N-succinylocarboxamide ribonucleotide) (SAICAR) to 5-aminoimidazole-4-
carboxamide ribonucleotide (AICAR) and fumarate."
- PMID:19405474: "ASL, a catalyst of key reactions in purine biosynthesis, is
normally a homotetramer in which three subunits contribute to each of four
active sites."
- Reactome R-HSA-73800 / R-HSA-73828: "The active form of this enzyme is a
cytosolic tetramer" and it mediates both reactions in vivo.

Localization

Cytosol. IDA (HPA immunofluorescence, GO_REF:0000052), TAS (Reactome), IBA. Also
reported to associate with the purinosome (multi-enzyme DNPS complex) under some
metabolic conditions [Reactome R-HSA-73800; PMID:27590927].

Disease

Adenylosuccinate lyase deficiency (ADSLD; MIM:103050), autosomal recessive.
Accumulation of dephosphorylated substrates SAICA-riboside (SAICAr) and
succinyladenosine (S-Ado); psychomotor/mental retardation, epilepsy, autistic
features. S-Ado/SAICAr ratio in CSF correlates with severity PMID:10888601.
Many characterised missense variants reduce activity (PMID:19405474 etc).

Annotation assessment summary

MF (core):
- GO:0004018 SAMP lyase β€” IDA x3 (PMID:19405474, 16973378) + IBA + IEA β†’ ACCEPT (core).
- GO:0070626 SAICAR lyase β€” IDA (PMID:27590927) + IBA + IEA β†’ ACCEPT (core).
- GO:0003824 catalytic activity (IEA/InterPro) β€” too general; MARK_AS_OVER_ANNOTATED
(parent of the two specific MFs already present).
- GO:0042802 identical protein binding (IDA PMID:16973378; IEA) β€” homotetramer, so
self-association is real, but bare-binding term is uninformative vs the enzymatic
MFs and complex CC β†’ KEEP_AS_NON_CORE (IDA), IEA duplicate KEEP_AS_NON_CORE.

CC (core = cytosol):
- GO:0005829 cytosol β€” IDA/TAS/IBA β†’ ACCEPT.
- GO:0032991 protein-containing complex (IDA PMID:16973378) β€” homotetramer =
protein-containing complex; correct but very general β†’ KEEP_AS_NON_CORE.

BP:
- GO:0006189 'de novo' IMP biosynthetic process (IEA) — ACCEPT core (SAICAR→AICAR
is step 2/2 of the IMP de novo pathway; UniProt PATHWAY).
- GO:0044208 'de novo' AMP biosynthetic process (IBA + IEA) — ACCEPT core (SAMP→AMP
is AMP-from-IMP step 2/2; UniProt PATHWAY).
- GO:0006164 purine nucleotide biosynthetic process (IC PMID:10888601) β€” ACCEPT
(correct, general parent).
- GO:0006167 AMP biosynthetic process (IDA PMID:11428554; IEA) β€” ACCEPT/KEEP; the
IDA in blood cells measures AMP-producing activity.
- GO:0009152 purine ribonucleotide biosynthetic process (IEA InterPro) β€” ACCEPT
(correct general parent).
- GO:0044209 AMP salvage (IEA Ensembl, GO_REF:0000107) β€” MISLEADING. ADSL's AMP
production (SAMP→AMP) is part of DE NOVO synthesis (and the purine nucleotide
cycle), not the salvage (hypoxanthine/adenine phosphoribosyltransferase) pathway.
β†’ MARK_AS_OVER_ANNOTATED (Ensembl ortholog electronic transfer, biologically off).
- GO:0006177 GMP biosynthetic process (IEA Ensembl) β€” REMOVE. GMP is made from IMP
by IMPDH + GMPS; ADSL is not on the GMP branch. Wrong IEA ortholog transfer.
- GO:0097294 'de novo' XMP biosynthetic process (IEA Ensembl) β€” REMOVE. XMP is made
from IMP by IMPDH; ADSL not involved. Wrong IEA ortholog transfer.
- GO:0009060 aerobic respiration (IEA Ensembl) β€” REMOVE. ADSL is a cytosolic purine
biosynthesis enzyme; fumarate release is not participation in aerobic respiration.
Over-propagated ortholog IEA.
- GO:0001666 response to hypoxia (IEA Ensembl) β€” REMOVE. No evidence ADSL itself is
a hypoxia-response effector; electronic ortholog transfer, not supportable.
- GO:0007584 response to nutrient (IEA Ensembl) β€” REMOVE. Electronic ortholog
transfer; not supportable for human ADSL.
- GO:0042594 response to starvation (IEA Ensembl) β€” REMOVE. Same.
- GO:0014850 response to muscle activity (IEA Ensembl) β€” REMOVE. ADSL is highly
expressed in muscle and participates in the purine nucleotide cycle there, but
"response to muscle activity" (a stimulus-response BP) is not a supportable
molecular role for ADSL from an electronic ortholog transfer. Over-propagation.

The GO_REF:0000107 (Ensembl Compara) block of stimulus/response and off-pathway
biosynthesis terms is the classic over-propagation cluster and is treated as such.

πŸ“„ View Raw YAML

id: P30566
gene_symbol: ADSL
product_type: PROTEIN
status: INITIALIZED
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: Adenylosuccinate lyase (ADSL; adenylosuccinase; EC 4.3.2.2) is a cytosolic
  homotetrameric enzyme of purine metabolism that catalyses two distinct beta-elimination
  (fumarate-releasing) reactions in the same active site. In de novo purine synthesis
  it cleaves SAICAR ((S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate)
  to AICAR plus fumarate, completing the step 2/2 that converts SAICAR toward IMP;
  and at the IMP-to-AMP branch it cleaves adenylosuccinate (S-AMP) to AMP plus fumarate.
  The enzyme therefore contributes to both de novo IMP biosynthesis and de novo AMP
  biosynthesis. It assembles as a homotetramer in which three subunits contribute
  residues to each of the four active sites, and can associate with other de novo
  purine synthesis enzymes in the purinosome. Loss-of-function variants cause adenylosuccinate
  lyase deficiency (ADSLD), an autosomal-recessive neurodevelopmental disorder marked
  by psychomotor/mental retardation, epilepsy and autistic features, with accumulation
  of the dephosphorylated substrates SAICA-riboside and succinyladenosine in body
  fluids.
alternative_products:
- name: '1'
  id: P30566-1
- name: 2 (Delta-ADSL)
  id: P30566-2
  sequence_note: VSP_000318
existing_annotations:
- term:
    id: GO:0070626
    label: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate
      lyase (fumarate-forming) activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: SAICAR-lyase (fumarate-forming) activity, one of the two core catalytic
      functions of ADSL. This IBA is fully consistent with the human experimental
      data and the enzyme's role in de novo IMP synthesis.
    action: ACCEPT
    reason: This is a core molecular function of ADSL, cleaving SAICAR to AICAR plus
      fumarate as step 2/2 of the de novo IMP pathway. The phylogenetic inference
      matches the human IDA (PMID:27590927) and UniProt.
    supported_by:
    - reference_id: file:human/ADSL/ADSL-uniprot.txt
      supporting_text: Catalyzes two non-sequential steps in de novo AMP synthesis
    - reference_id: PMID:19405474
      supporting_text: the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide
        ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide
        (AICAR) and fumarate
- term:
    id: GO:0004018
    label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: enables
  review:
    summary: Adenylosuccinate (S-AMP) lyase (fumarate-forming) activity, the second
      core catalytic function of ADSL, cleaving S-AMP to AMP plus fumarate at the
      IMP-to-AMP branch.
    action: ACCEPT
    reason: Core molecular function, corroborated by human IDA data (PMID:19405474,
      PMID:16973378) and UniProt catalytic-activity annotation (EC 4.3.2.2, Rhea RHEA:16853).
    supported_by:
    - reference_id: PMID:19405474
      supporting_text: the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: is_active_in
  review:
    summary: ADSL is a cytosolic enzyme; its active form is a cytosolic tetramer.
      This localization is supported by IBA, IDA (HPA) and TAS (Reactome).
    action: ACCEPT
    reason: Cytosolic localization is well established and consistent across phylogenetic,
      immunofluorescence and Reactome evidence.
    supported_by:
    - reference_id: Reactome:R-HSA-73800
      supporting_text: The active form of this enzyme is a cytosolic tetramer
- term:
    id: GO:0044208
    label: '''de novo'' AMP biosynthetic process'
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  qualifier: involved_in
  review:
    summary: ADSL catalyses the final step (S-AMP to AMP) of de novo AMP biosynthesis
      from IMP. This is a core biological process for the gene.
    action: ACCEPT
    reason: The SAMP-to-AMP reaction is AMP-from-IMP step 2/2 of the de novo AMP pathway,
      as stated in the UniProt PATHWAY annotation. IBA is at the correct level.
    supported_by:
    - reference_id: file:human/ADSL/ADSL-uniprot.txt
      supporting_text: 'AMP biosynthesis via de novo pathway; AMP'
- term:
    id: GO:0003824
    label: catalytic activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: enables
  review:
    summary: Root-level catalytic activity term from InterPro2GO. Not wrong, but far
      too general given the two specific lyase activities (GO:0004018, GO:0070626)
      are already annotated with experimental evidence.
    action: MARK_AS_OVER_ANNOTATED
    reason: This is an uninformative parent of the specific molecular functions ADSL
      is already annotated to. It adds no information beyond the specific lyase terms.
    supported_by:
    - reference_id: file:human/ADSL/ADSL-uniprot.txt
      supporting_text: Catalyzes two non-sequential steps in de novo AMP synthesis
- term:
    id: GO:0004018
    label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: Electronic annotation (ARBA/RHEA:16853) of the S-AMP lyase activity,
      redundant with and corroborated by the experimental IDA annotations.
    action: ACCEPT
    reason: Correct molecular function derived from the EC/Rhea mapping; matches the
      human experimental data.
    supported_by:
    - reference_id: PMID:19405474
      supporting_text: the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
- term:
    id: GO:0009152
    label: purine ribonucleotide biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  qualifier: involved_in
  review:
    summary: General purine ribonucleotide biosynthesis process, correctly capturing
      ADSL's role in de novo IMP/AMP synthesis, though broader than the specific de
      novo terms.
    action: ACCEPT
    reason: A correct, if general, biological-process parent. ADSL participates in
      purine ribonucleotide biosynthesis via de novo IMP and AMP synthesis.
    supported_by:
    - reference_id: file:human/ADSL/ADSL-uniprot.txt
      supporting_text: Catalyzes two non-sequential steps in de novo AMP synthesis
- term:
    id: GO:0001666
    label: response to hypoxia
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Stimulus-response process transferred electronically from a rat ortholog
      via Ensembl Compara. There is no evidence that human ADSL functions as an effector
      in the hypoxia response; this is an over-propagated ortholog IEA.
    action: REMOVE
    reason: ADSL is a cytosolic purine-biosynthesis lyase. "Response to hypoxia" is
      a stimulus-response biological process not supported by any experimental data
      for ADSL, and is a classic Ensembl-Compara over-propagation from an ortholog.
- term:
    id: GO:0006167
    label: AMP biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: AMP biosynthetic process (general parent of de novo AMP biosynthesis),
      correctly capturing ADSL's production of AMP from S-AMP.
    action: ACCEPT
    reason: ADSL produces AMP as the second step of AMP-from-IMP; this general term
      is correct and is also supported by the human IDA (PMID:11428554).
    supported_by:
    - reference_id: PMID:19405474
      supporting_text: the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
- term:
    id: GO:0006177
    label: GMP biosynthetic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: GMP biosynthesis is not catalysed or supported by ADSL. GMP is produced
      from IMP by IMP dehydrogenase and GMP synthase; ADSL acts on the AMP branch,
      not the GMP branch.
    action: REMOVE
    reason: Biochemically incorrect. ADSL has no role in GMP synthesis; this is an
      erroneous Ensembl-Compara ortholog transfer. The enzyme's reactions (SAICAR
      to AICAR, and S-AMP to AMP) lie on the IMP and AMP branches only.
- term:
    id: GO:0006189
    label: '''de novo'' IMP biosynthetic process'
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: ADSL contributes to de novo IMP biosynthesis via its SAICAR-lyase step
      (SAICAR to AICAR + fumarate), which is step 2/2 in the conversion of SAICAR
      toward IMP. Core biological process.
    action: ACCEPT
    reason: Correct core process. The UniProt PATHWAY annotation places this SAICAR-lyase
      reaction within de novo IMP biosynthesis.
    supported_by:
    - reference_id: file:human/ADSL/ADSL-uniprot.txt
      supporting_text: 'IMP biosynthesis via de novo pathway'
- term:
    id: GO:0007584
    label: response to nutrient
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Stimulus-response process transferred electronically from a rat ortholog.
      No experimental support for human ADSL acting as a nutrient-response effector.
    action: REMOVE
    reason: Over-propagated Ensembl-Compara ortholog IEA; not a supportable molecular
      role for human ADSL, which is a constitutive purine-biosynthesis enzyme.
- term:
    id: GO:0009060
    label: aerobic respiration
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Aerobic respiration is a mitochondrial process; ADSL is a cytosolic purine-biosynthesis
      lyase. Fumarate release by ADSL does not constitute participation in aerobic
      respiration.
    action: REMOVE
    reason: Biologically incorrect over-propagation via Ensembl Compara. ADSL is not
      part of the respiratory chain or TCA cycle; its product fumarate feeds general
      metabolism but that does not make ADSL a participant in aerobic respiration.
- term:
    id: GO:0014850
    label: response to muscle activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Although ADSL is highly expressed in skeletal muscle and participates
      in the purine nucleotide cycle there, "response to muscle activity" is a stimulus-response
      biological process electronically transferred from a rat ortholog, without experimental
      support for human ADSL as an effector of this response.
    action: REMOVE
    reason: Over-propagated Ensembl-Compara ortholog IEA. Muscle expression does not
      justify a stimulus-response BP annotation; ADSL's role in muscle is its constitutive
      purine-cycle catalysis.
- term:
    id: GO:0042594
    label: response to starvation
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: Stimulus-response process transferred electronically from a rat ortholog.
      No experimental support for human ADSL as a starvation-response effector.
    action: REMOVE
    reason: Over-propagated Ensembl-Compara ortholog IEA, not supportable for human
      ADSL.
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: enables
  review:
    summary: Self-association is real (ADSL is a homotetramer), but "identical protein
      binding" is an uninformative molecular-function term compared with the enzyme's
      catalytic activities and its "protein-containing complex" annotation. This IEA
      duplicates the IDA below.
    action: KEEP_AS_NON_CORE
    reason: The homotetrameric assembly makes identical-protein binding technically
      correct, but it is non-core relative to the catalytic MFs. Retain as non-core;
      the homotetramer is better captured by GO:0032991 and the SUBUNIT annotation.
    supported_by:
    - reference_id: PMID:19405474
      supporting_text: ASL, a catalyst of key reactions in purine biosynthesis, is
        normally a homotetramer in which three subunits contribute to each of four
        active sites
- term:
    id: GO:0044208
    label: '''de novo'' AMP biosynthetic process'
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: involved_in
  review:
    summary: Electronic annotation of de novo AMP biosynthesis (UniPathway UPA00075),
      redundant with the IBA and consistent with the S-AMP-to-AMP reaction.
    action: ACCEPT
    reason: Correct core process, matching the UniProt de novo AMP biosynthesis pathway
      annotation.
    supported_by:
    - reference_id: file:human/ADSL/ADSL-uniprot.txt
      supporting_text: 'AMP biosynthesis via de novo pathway; AMP'
- term:
    id: GO:0044209
    label: AMP salvage
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: ADSL produces AMP as part of DE NOVO purine synthesis (and the purine
      nucleotide cycle), not the salvage pathway. AMP salvage refers to recovery of
      AMP from adenine/adenosine via APRT and adenosine kinase, in which ADSL plays
      no part.
    action: MARK_AS_OVER_ANNOTATED
    reason: Misleading Ensembl-Compara ortholog IEA. ADSL's S-AMP-to-AMP reaction
      is de novo AMP biosynthesis, correctly captured by GO:0044208/GO:0006167; annotating
      it to AMP salvage misassigns the pathway context.
- term:
    id: GO:0070626
    label: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate
      lyase (fumarate-forming) activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  qualifier: enables
  review:
    summary: Electronic annotation (ARBA/RHEA:23920) of the SAICAR-lyase activity,
      redundant with and corroborated by the human IDA and IBA annotations.
    action: ACCEPT
    reason: Correct core molecular function from the EC/Rhea mapping; matches the human
      experimental data (PMID:27590927).
    supported_by:
    - reference_id: PMID:19405474
      supporting_text: the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide
        ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide
        (AICAR) and fumarate
- term:
    id: GO:0097294
    label: '''de novo'' XMP biosynthetic process'
  evidence_type: IEA
  original_reference_id: GO_REF:0000107
  qualifier: involved_in
  review:
    summary: XMP is synthesized from IMP by IMP dehydrogenase; ADSL is not involved
      in the XMP branch. This is an erroneous Ensembl-Compara ortholog transfer.
    action: REMOVE
    reason: Biochemically incorrect. ADSL acts on the SAICAR-to-IMP and IMP-to-AMP
      branches, not on the IMP-to-XMP branch. No support for XMP biosynthesis.
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: IDA
  original_reference_id: GO_REF:0000052
  qualifier: located_in
  review:
    summary: Immunofluorescence (HPA) localizes ADSL to the cytosol, consistent with
      the enzyme's cytosolic tetrameric active form.
    action: ACCEPT
    reason: Direct experimental (HPA immunofluorescence) evidence for cytosolic localization,
      concordant with IBA and Reactome TAS.
    supported_by:
    - reference_id: Reactome:R-HSA-73800
      supporting_text: The active form of this enzyme is a cytosolic tetramer
- term:
    id: GO:0004018
    label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
  evidence_type: IDA
  original_reference_id: PMID:19405474
  qualifier: enables
  review:
    summary: Direct assay of the S-AMP-to-AMP + fumarate reaction on purified recombinant
      human ADSL and disease-associated mutants. Core molecular function.
    action: ACCEPT
    reason: Strong direct experimental evidence for the adenylosuccinate (S-AMP) lyase
      activity, measured continuously as SAMP is converted to AMP and fumarate.
    supported_by:
    - reference_id: PMID:19405474
      supporting_text: as 60 ΞΌM SAMP is converted to AMP and fumarate
- term:
    id: GO:0070626
    label: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate
      lyase (fumarate-forming) activity
  evidence_type: IDA
  original_reference_id: PMID:27590927
  qualifier: enables
  review:
    summary: SAICAR-lyase activity demonstrated in the context of de novo purine synthesis;
      CRISPR knockout of ADSL in HeLa cells leads to accumulation of its substrate,
      confirming the in vivo lyase step. Core molecular function.
    action: ACCEPT
    reason: Direct experimental evidence supporting the SAICAR-lyase activity; substrate
      accumulation on knockout confirms the enzyme performs this step in cells.
    supported_by:
    - reference_id: PMID:27590927
      supporting_text: an accumulation of the substrate(s) for the knocked out enzyme
        was identified
- term:
    id: GO:0032991
    label: protein-containing complex
  evidence_type: IDA
  original_reference_id: PMID:16973378
  qualifier: part_of
  review:
    summary: ADSL is a homotetramer, i.e. a protein-containing complex. Direct evidence
      from analytical ultracentrifugation of the purified recombinant enzyme (tetramer,
      ~220 kDa). Correct but very general.
    action: KEEP_AS_NON_CORE
    reason: The homotetrameric assembly is real and experimentally demonstrated, but
      "protein-containing complex" is an uninformative CC parent; the specific homotetramer
      state is better described in the SUBUNIT annotation. Retain as non-core.
    supported_by:
    - reference_id: PMID:16973378
      supporting_text: the histidine-tagged enzyme is in tetrameric form with a molecular
        weight of 220 kDa
    - reference_id: file:human/ADSL/ADSL-uniprot.txt
      supporting_text: Homotetramer. Residues from neighboring subunits contribute
        catalytic and substrate-binding residues to each active site.
- term:
    id: GO:0042802
    label: identical protein binding
  evidence_type: IDA
  original_reference_id: PMID:16973378
  qualifier: enables
  review:
    summary: Self-association into a homotetramer is experimentally demonstrated (analytical
      ultracentrifugation). "Identical protein binding" is technically correct but
      uninformative relative to the catalytic MFs and the complex annotation.
    action: KEEP_AS_NON_CORE
    reason: Homo-oligomerization is real (homotetramer), so the term is not wrong,
      but per curation guidelines bare binding terms are non-core; the functionally
      informative annotations are the two lyase MFs and GO:0032991. Retain as non-core.
    supported_by:
    - reference_id: PMID:16973378
      supporting_text: the histidine-tagged enzyme is in tetrameric form with a molecular
        weight of 220 kDa
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-73800
  qualifier: located_in
  review:
    summary: Reactome (SAICAR => AICAR + Fumarate) places ADSL in the cytosol; the
      active enzyme is a cytosolic tetramer. Concordant with IDA and IBA.
    action: ACCEPT
    reason: Traceable author statement supporting cytosolic localization, consistent
      with all other localization evidence.
    supported_by:
    - reference_id: Reactome:R-HSA-73800
      supporting_text: The active form of this enzyme is a cytosolic tetramer
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-73828
  qualifier: located_in
  review:
    summary: Reactome (adenylosuccinate => AMP + fumarate) places ADSL in the cytosol;
      the active enzyme is a cytosolic tetramer.
    action: ACCEPT
    reason: Traceable author statement supporting cytosolic localization, consistent
      with all other localization evidence.
    supported_by:
    - reference_id: Reactome:R-HSA-73828
      supporting_text: The active form of this enzyme is a cytosolic tetramer
- term:
    id: GO:0006164
    label: purine nucleotide biosynthetic process
  evidence_type: IC
  original_reference_id: PMID:10888601
  qualifier: involved_in
  review:
    summary: Curator inference (from the SAMP-lyase activity, GO:0004018) that ADSL
      is involved in purine nucleotide biosynthesis. Correct general biological process.
    action: ACCEPT
    reason: ADSL is a bifunctional enzyme of de novo purine synthesis and purine nucleotide
      recycling; the general purine nucleotide biosynthetic process term is appropriate.
    supported_by:
    - reference_id: PMID:10888601
      supporting_text: Adenylosuccinate lyase (ADSL) is a bifunctional enzyme acting
        in de novo purine synthesis and purine nucleotide recycling
- term:
    id: GO:0006167
    label: AMP biosynthetic process
  evidence_type: IDA
  original_reference_id: PMID:11428554
  qualifier: involved_in
  review:
    summary: ADSL activity measured in blood cells, with the study discussing its
      role in regulating cellular AMP levels. Supports involvement in AMP biosynthesis.
    action: ACCEPT
    reason: Direct measurement of ADSL activity and its role in cellular AMP regulation;
      consistent with the enzyme's S-AMP-to-AMP reaction in de novo AMP synthesis.
    supported_by:
    - reference_id: PMID:11428554
      supporting_text: The biological role of adenylosuccinate lyase and its importance
        in regulating cellular levels of AMP is discussed
- term:
    id: GO:0004018
    label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
  evidence_type: IDA
  original_reference_id: PMID:16973378
  qualifier: enables
  review:
    summary: Recombinant human ADSL was characterized for its S-AMP lyase activity,
      with kinetic parameters (Vmax, Km) determined for S-AMP. Core molecular function.
    action: ACCEPT
    reason: Direct experimental characterization of the adenylosuccinate (S-AMP) lyase
      activity of purified human ADSL, defining EC 4.3.2.2 for the human enzyme.
    supported_by:
    - reference_id: PMID:16973378
      supporting_text: The histidine-tagged and non-tagged adenylosuccinate lyases
        exhibit similar values of Vmax and Km for S-AMP
core_functions:
- description: Adenylosuccinate (S-AMP) lyase activity - cleaves N6-(1,2-dicarboxyethyl)-AMP
    (S-AMP) to AMP and fumarate, the second step of de novo AMP biosynthesis from
    IMP.
  molecular_function:
    id: GO:0004018
    label: N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity
  directly_involved_in:
  - id: GO:0044208
    label: '''de novo'' AMP biosynthetic process'
  locations:
  - id: GO:0005829
    label: cytosol
  supported_by:
  - reference_id: PMID:19405474
    supporting_text: the cleavage of adenylosuccinate (SAMP)1 to AMP and fumarate
  - reference_id: PMID:16973378
    supporting_text: The histidine-tagged and non-tagged adenylosuccinate lyases exhibit
      similar values of Vmax and Km for S-AMP
- description: SAICAR-lyase activity - cleaves SAICAR to AICAR and fumarate, step 2/2
    of de novo IMP biosynthesis, contributing to purine nucleotide biosynthesis.
  molecular_function:
    id: GO:0070626
    label: (S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido) succinate
      lyase (fumarate-forming) activity
  directly_involved_in:
  - id: GO:0006189
    label: '''de novo'' IMP biosynthetic process'
  locations:
  - id: GO:0005829
    label: cytosol
  supported_by:
  - reference_id: PMID:19405474
    supporting_text: the conversion of 5-aminoimidazole-4-(N-succinylocarboxamide
      ribonucleotide) (SAICAR) to 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR)
      and fumarate
  - reference_id: PMID:27590927
    supporting_text: an accumulation of the substrate(s) for the knocked out enzyme
      was identified
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO
    terms
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000052
  title: Gene Ontology annotation based on curation of immunofluorescence data
  findings: []
- id: GO_REF:0000107
  title: Automatic transfer of experimentally verified manual GO annotation data to
    orthologs using Ensembl Compara
  findings: []
  reference_review:
    relevance: LOW
    correctness: UNVERIFIED
    review_notes: Source of a block of stimulus-response and off-pathway biosynthesis
      IEAs (hypoxia, nutrient, starvation, muscle activity, aerobic respiration, GMP,
      XMP, AMP salvage) transferred from rodent orthologs. Several are biologically
      unsupportable for human ADSL and are flagged for REMOVE / MARK_AS_OVER_ANNOTATED.
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10888601
  title: Human adenylosuccinate lyase (ADSL), cloning and characterization of full-length
    cDNA and its isoform, gene structure and molecular basis for ADSL deficiency in
    six patients.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Establishes ADSL as a bifunctional de novo purine synthesis/recycling
      enzyme, characterizes the enzymatically inactive isoform 2, and defines the
      molecular basis of ADSL deficiency in six patients (abstract verified against
      cached record).
- id: PMID:11428554
  title: Determination, activity and biological role of adenylosuccinate lyase in
    blood cells.
  findings: []
  reference_review:
    relevance: MEDIUM
    correctness: VERIFIED
    review_notes: Measures ADSL activity in human blood cells and discusses its role
      in regulating cellular AMP levels; supports the AMP biosynthetic process annotation.
- id: PMID:16973378
  title: Expression, purification, and characterization of stable, recombinant human
    adenylosuccinate lyase.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Defines the recombinant human enzyme's S-AMP lyase kinetics (Vmax/Km)
      and demonstrates the homotetramer (~220 kDa) by analytical ultracentrifugation;
      basis for the MF, identical-protein-binding, and protein-complex annotations.
- id: PMID:19405474
  title: Biochemical and biophysical analysis of five disease-associated human adenylosuccinate
    lyase mutants.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Full text available; explicitly states the two beta-elimination
      reactions (SAMP->AMP+fumarate; SAICAR->AICAR+fumarate) and the homotetramer
      with three subunits per active site. Primary support for both core MFs.
- id: PMID:27590927
  title: CRISPR-Cas9 induced mutations along de novo purine synthesis in HeLa cells
    result in accumulation of individual enzyme substrates and affect purinosome formation.
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: CRISPR knockout of de novo purine synthesis enzymes (including ADSL)
      in HeLa cells causes accumulation of the knocked-out enzyme's substrate and
      impairs purinosome assembly; supports the in vivo SAICAR-lyase step.
- id: Reactome:R-HSA-73800
  title: SAICAR => AICAR + Fumarate
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Reactome reaction for the SAICAR-lyase step; states the active enzyme
      is a cytosolic tetramer and mediates both reactions in vivo.
- id: Reactome:R-HSA-73828
  title: adenylosuccinate => adenosine 5'-monophosphate + fumarate
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Reactome reaction for the S-AMP lyase step; states the active enzyme
      is a cytosolic tetramer.
- id: file:human/ADSL/ADSL-uniprot.txt
  title: UniProtKB P30566 (PUR8_HUMAN) adenylosuccinate lyase record
  findings: []
  reference_review:
    relevance: HIGH
    correctness: VERIFIED
    review_notes: Curated UniProt record; source of the dual catalytic-activity, de
      novo IMP/AMP pathway, homotetramer subunit, and ADSLD disease annotations.